Iron Deficiency in Acute Myocardial Infarction: Prevalence Pilot Study
Launched by SOUTH TEES HOSPITALS NHS FOUNDATION TRUST · Jun 8, 2024
Trial Information
Current as of June 18, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the relationship between iron levels and heart attacks, specifically focusing on patients who have recently experienced a heart attack, also known as a myocardial infarction. Each year, around 86,000 people in the UK have heart attacks, and understanding how iron levels affect recovery could help improve care for these patients. This initial study will involve around 70 patients at one NHS Trust who agree to participate. Researchers will check the iron levels in their blood and collect information from their medical records to gather insights that will help plan a larger study in the future.
To be eligible for this trial, participants must be adults who have had a heart attack within the past 10 days and must provide their consent to take part. If you or someone you know fits this description, participating in this study will involve a simple blood test to check iron levels, along with the review of medical records. This research aims to better understand how common low iron levels are in heart attack patients, which could lead to improved treatments and care strategies down the line.
Gender
ALL
Eligibility criteria
- Inclusion:
- • 1. - Adults patients who sign an informed consent form.
- • 2. - Type 1 myocardial infarction within the previous 10 days
- • Exclusion
- • 1 - Not fulfilling inclusion criteria
About South Tees Hospitals Nhs Foundation Trust
South Tees Hospitals NHS Foundation Trust is a leading healthcare provider in the UK, dedicated to delivering high-quality patient care and advancing medical research through innovative clinical trials. With a commitment to excellence, the Trust operates multiple hospitals and services, focusing on a patient-centered approach and collaboration with academic institutions and industry partners. Their clinical trial programs aim to improve treatment outcomes and enhance the understanding of various health conditions, ensuring that cutting-edge therapies are accessible to patients while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Middlesbrough, Teesside, United Kingdom
Patients applied
Trial Officials
David Austin, MD
Principal Investigator
South Tees Hospitals NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported